Plasma serotonin level after 1 day of fluoxetine treatment: A biological predictor for antidepressant response?

Psychopharmacology

Volumn 143, Issue 1, 1999, Pages 97-101

  Alvarez, Jean Claude ^a   Gluck, Nathalie ^b   Fallet, Alain ^b   Grégoire, Anne ^a   Chevalier, Jean François ^b   Advenier, Charles ^a   Spreux Varoquaux, Odile ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Service de Psychiatrie   (France)

Author keywords

Biological predictor; Fluoxetine and norfluoxetine; Major depressive episode; Plasma 5 HT; Serum 5 HT

Indexed keywords

BIOLOGICAL MARKER; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 0032925499     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050924     Document Type: Article

References (24)

1. Alvarez JC, Kollenbach K, Vanier B, Plas J, Chevalier JF, Advenier C, Spreux-Varoquaux O (1997) Relationship between response to IV clomipramine, plasma drug levels, blood 5-HT, plasma 5-HIAA and HVA in depressed patients. Biol Psychiatry 42: 104S
2. Alvarez JC, Bothua D, Collignon I, Advenier C, Spreux-Varoquaux O (1998) Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high performance liquid chromatography with ultraviolet detection. J Chromatogr B 707:175-180
3. Balon R (1989) Biological predictors of antidepressant outcome. Clin Neuropharmacol 31:449-455
4. Celada P, Perez J, Alvarez E, Artigas F (1992a) Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. J Clin Psychopharmacol 12:309-315
5. Celada P, Dolera M, Alvarez E, Artigas F (1992b) Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affect Disord 25: 243-250
6. Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry 46:89-99
7. Kelly MW, Perry PJ, Holstad SG, Garvey MJ (1989) Serum fluoxetine and norfluoxetine concentrations and antidepressant response. Ther Drug Monit 11:165-170
8. 2 receptors, plasma free serotonin and platelet serotonin levels in depressed patients after clomipramine treatment. Neuropsychopharmacology 10:4S
9. 3H] imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta Psychiatr Scand 83:125-133
10. Montgomery SA (1991) Clinical aspects of onset of action of anti-depressant efficacy. Biol Psychiatry 29:114S
11. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389
12. Ortiz J, Artigas F, Gelpi E (1988) Serotoninergic status in human blood. Life Sci 43:983-990
13. Ortiz J, Mariscot C, Alvarez E, Artigas F (1993) Effects of the anti-depressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. J Affect Disord 29: 227-234
14. Ferez V, Bel N, Celada P, Ortiz J, Alvarez E, Artigas F (1998) Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments. J Clin Psychopharmacol 18:222-230
15. Potter WZ, Rudorfer MW, Manji H (1991) The pharmacologic treatment of depression. New Engl J Med 325:633-642
16. Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetteberg L, Asberg M (1980) Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo. Psychopharmacology 67:1-7
17. Sarrias MJ, Artigas F, Martinez E, Gelpi E, Alvarez E, Udina C, Casas M (1987) Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biol Psychiatry 22: 1429-1438
18. Spreux-Varoquaux O, Gailledreau J, Bothua D, Brion S, Advenier C, Pays M (1991) Extensive decrease of plasma free serotonin and platelet serotonin levels after clomipramine treatment in depressed patients. Biol Psychiatry 29:606S
19. Spreux-Varoquaux O, Gailledreau J, Vanier B, Bothua D, Plas J, Chevalier JF, Advenier C, Pays M, Brion S (1996) Initial increase of plasma serotonin: a biological predictor for the anti-depressant response to clomipramine? Biol Psychiatry 40: 465-473
20. Tyrer SP, Marshall EF, Griffiths HW (1990) The relationship between response to fluoxetine, plasma drug levels, imipramine binding to platelet membranes and whole-blood 5-HT. Prog Neuropsychopharmacol 14:797-805
21. Verbeuren TJ (1989) Synthesis, storage, release and metabolism of 5-hydroxytryptamine in peripheral tissues. In: Fozard JR (ed) The peripheral actions of 5-hydroxytryptamine. Oxford University Press, Oxford, pp 1-25
22. 3H] imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J Affect Disord 20:101-113
23. Wirz-Justice A, Puehringer W (1978) Chronic treatment with clomipramine or maprotiline depletes platelet serotonin and modifies its diurnal rhythm. Prog Neuropsychopharmacol Biol Psychiatr 2:217-224
24. Wong DT, Bymaster FP, Engleman EA (1995) Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci 57:411-441